Use of single probiotic strain, Saccharomyces boulardii, in a cohort of hospitalized patients administered antibiotics frequently associated with hospital onset Clostridioides difficile infection (HO-CDI), resulted in a significant HO-CDI risk reduction, especially when started early relative to antibiotics.